[1] Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
|
[2] LEE WM. Drug-induced acute liver failure[J]. Clin Liver Dis,2013,17(4):575-586.
|
[3] DANAN G,BENICHOU C. Causality assessment of adverse reactions to drug-I. A novel method based on the conclusions of international consensus meetings:Application to drug-induced liver injury[J]. Clin Epidemiol,1993,46(11):1323-1330.
|
[4] Branch of Hepatobiliary Diseases,China Association of Chinese Medicine,Branch of Chinese Patent Medicine,China Association of Chinese Medicine. Guidelines for the clinical management of herb-induced liver injury[J]. J Clin Hepatol,2016,32(5):835-843.(in Chinese)中华中医药学会肝胆病分会,中华中医药学会中成药分会.中草药相关肝损伤临床诊疗指南[J].临床肝胆病杂志,2016,32(5):835-843.
|
[5] Chinese Society of Hepatology,Chinese Medical Association.Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol,2019,35(11):2408-2425.(in Chinese)中华医学会肝病学分会.肝硬化诊治指南[J].临床肝胆病杂志,2019,35(11):2408-2425.
|
[6] Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association; Severe Liver Disease and Artificial Liver Group,Chinese Society of Hepatology,Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol,2019,35(1):38-44.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].临床肝胆病杂志,2019,35(1):38-44.
|
[7] GUO Y,FAN Y,QIU J,et al. Polymorphisms in CTLA4 influence incidence of drug-induced liver injury after renal transplantation in Chinese recipients[J]. PLo S One, 2012,7(12):e51723.
|
[8] XU LN,LI Y,PENG JY. microRNA and drug-induced liver injury[J]. Chin J Clin Pharmacol Ther,2020,25(7):803-809.(in Chinese)许丽娜,李月,彭金咏.microRNA与药物性肝损伤[J].中国临床药理学与治疗学,2020,25(7):803-809.
|
[9] TENG GJ,LI BS,ZHAO J,et al. Characteristics and change trend of drug-induced liver injury in recent 10 years[J]. Chin Hepatol,2014,19(5):329-331.(in Chinese)腾光菊,李保森,赵军,等.近10年药物性肝损伤患者的特点及变化趋势[J].肝脏,2014,19(5):329-331.
|
[10] CHO J,KIM L,LI Z,et al. Sex bias in experimental immunemediated,drug-induced liver injury in BALB/C mice:Suggestde roles for tregs,estrogen,and IL-6[J]. PLo S One,2013,8:e61186.
|
[11] LEE WM. Drug-induced hepatotoxicity[J]. N Engl J Med,1995,333(17):1118-1127.
|
[12] ZHANG P,KE YM,FAN XC,et al. Clinical analysis of 324 cases of drug-induced liver injury[J]. World Chin J Dig,2013,21(33):3720-3723.(in Chinese)张平,柯玉满,樊小春,等.药物性肝损伤临床分析324例[J].世界华人消化杂志,2013,21(33):3720-3723.
|
[13] CHALASANI N,BONKOVSKY HL,FONTANA R,et al. Features and outcomes of 899 patients with drug-induced liver injury:The DILIN prospective study[J]. Gastroenterology,2015,148(7):1340-1352.
|
[14] LUCENA MI. Phenotypic characterization of idiosyncratic drugin-duced liver injury:The influence of age and sex[J]. Hepatology,2009,49(6):2001-2009.
|
[15] REUBEN A,KOCH DG,LEE WM,et al. Drug-induced acute liver failure:Results of a U. S. multicenter,prospective study[J]. Hepatology,2010,52(6):2065-2076.
|